Spain Pharmaceuticals and Healthcare Report Q2 2014

Business Monitor International
March 26, 2014
101 Pages - SKU: BMI5222040
Countries covered: Spain

Spain Pharmaceuticals and Healthcare Report Q2 2014

BMI View: Despite the Spanish economy returning to growth in 2014, the country's pharmaceuticals andhealthcare sectors show no sign of following suit. The Spanish government's ongoing cash flow troublesand aggressive fiscal austerity measures, which focus heavily on cost containment in the healthcare sector,will continue to negatively impact pharmaceutical companies operating in Spain.

Headline Expenditure Projections

Pharmaceuticals: EUR24.09bn (US$31.79bn) in 2013 to EUR22.81bn (US$28.97bn) in 2014; -5.3% inlocal currency terms and -8.9% in US dollar terms.

Healthcare: EUR98.71bn (US$130.30bn) in 2013 to EUR98.57bn (US$125.19bn) in 2014; -0.1% inlocal currency terms and -3.9% in US dollar terms.



More Prescription Drugs reports by Business Monitor International

Japan Pharmaceuticals and Healthcare Report Q1 2015 by Business Monitor International
Japan Pharmaceuticals and Healthcare Report Q1 2015BMI View: The Japanese pharmaceutical market continues to hold strong rewards for innovativepharmaceutical companies. This is driven by the ...
Tanzania Pharmaceuticals and Healthcare Report Q1 2015 by Business Monitor International
Tanzania Pharmaceuticals and Healthcare Report Q1 2015BMI View: We expect the continuing depreciation of the Tanzanian shilling to make imports of rawmaterials increasingly expensive for ...
Romania Pharmaceuticals and Healthcare Report Q1 2015 by Business Monitor International
Romania Pharmaceuticals and Healthcare Report Q1 2015BMI View: Romania's claw back tax is likely to see a revision as domestic companies lobby to push theburden ...
Latvia Pharmaceuticals and Healthcare Report Q1 2015 by Business Monitor International
Latvia Pharmaceuticals and Healthcare Report Q1 2015BMI View: Market growth forecasts are strong although the country will continue to present a modestopportunity to larger multinational ...
See all reports like this >>

More Spain Prescription Drugs reports

Vancomycin: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations - France, Germany, Italy, Japan, Spain, UK, USA by VPGMarketResearch.com
This new report from VPGMarketResearch.com provides analysis of Vancomycin testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales ...
Valproic Acid: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations - France, Germany, Italy, Japan, Spain, UK, USA by VPGMarketResearch.com
This new report from VPGMarketResearch.com provides analysis of Valproic Acid testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and ...
Topirimate: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations - France, Germany, Italy, Japan, Spain, UK, USA by VPGMarketResearch.com
This new report from VPGMarketResearch.com provides analysis of Topirimate testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales ...
Tobramycin: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations - France, Germany, Italy, Japan, Spain, UK, USA by VPGMarketResearch.com
This new report from VPGMarketResearch.com provides analysis of Tobramycin testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales ...
See all reports like this >>

 

SELECT A LICENSE

    Report with 3 quarterly updates  USD 1,295  
    Report with 3 quarterly updates
3 User License
  USD 1,945  
    Report with 3 quarterly updates
5 User License
  USD 2,500  
    Report with 3 quarterly updates
Departmental/Site License
  USD 2,995  
    Global Site License Fulfilled by Publisher  USD 6,995  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!